Literature DB >> 33475497

SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.

Hassan Yousefi1, Arash Poursheikhani2, Zahra Bahmanpour3, Mousa Vatanmakanian1, Mohammad Taheri4, Ladan Mashouri5, Suresh K Alahari6.   

Abstract

Although 70 % of the genome is transcribed to RNA in humans, only ∼2% of these transcripts are translated into proteins. The rest of the transcripts are defined as noncoding RNAs, including Long noncoding RNAs (LncRNAs) and MicroRNAs (miRNAs) that mostly function post-transcriptionally to regulate the gene expression. The outbreak of a novel coronavirus (SARS-CoV) has caused a major public health concern across the globe. The SARS-CoV is the seventh coronavirus that is known to cause human disease. There are currently no promising antiviral drugs with proven efficacy nor are there vaccines for its prevention. As of August 10, 2020, SARS-CoV has been infected more than 13 million cases in more than 213 countries, with an estimated mortality rate of ∼3 %. Thus, it is of utmost important priority to develop novel therapies for COVID-19. It is not fully investigated whether noncoding RNAs regulate signaling pathways that SARS-CoV involved in. Hence, computational analysis of the noncoding RNA interactions and determining importance of key regulatory noncoding RNAs in antiviral defense mechanisms will likely be helpful in developing new drugs to attack SARS-CoV infection. To elucidate this, we utilized bioinformatic approaches to find the interaction network of SARS-CoV/human proteins, miRNAs, and lncRNAs. We found TGF-beta signaling pathway as one of the potential interactive pathways. Furthermore, potential miRNAs/lncRNAs networks that the virus might engage during infection in human host cells have been shown. Altogether, TGF-beta signaling pathway as well as hub miRNAs, and LncRNAs involve during SARS-CoV pathogenesis can be considered as potential therapeutic targets.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Bioinformatics analysis; Covid-19; Noncoding RNA, miRNA, lncRNA; SARS-CoV

Year:  2020        PMID: 33475497      PMCID: PMC7386606          DOI: 10.1016/j.biopha.2020.110548

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


Introduction

Viral protein complexity is basically limited by their relatively small genomes; therefore, critical functions are mainly accomplished by cooperation between host and viral protein machinery. This requirement makes the study of host–viral interactions is critical for the understanding of viral pathogenicity [1]. COVID-19 has infected over 20 million people and has killed more than 737,000 people by mid August 2020. This has driven the world into hysteria and panic, causing social and economic disruption. There are currently no promising antiviral drugs or vaccines to combat COVID-19. This is largely due to our limited knowledge about the molecular mechanisms of the virus pathogenesis [2]. MicroRNAs (miRNAs) are short non-coding RNAs that inhibit the expression of their target genes by directly binding to target mRNAs [3]. Long noncoding RNAs (lncRNAs) are a category of cellular RNAs that are longer than 200 nucleotides in length. Accumulating evidence suggests that miRNAs and lncRNAs play key roles in different disease pathogenesis [4,5]. More specifically, miRNA have common binding sites for both mRNAs and lncRNAs; thus, lncRNAs can act as competitive endogenous RNA (ceRNA) to suppress the miRNA function or act as precursors and encode miRNAs [4]. These miRNA regulatory functions have been estimated to regulate around 60 % of mammalian genes [6]. LncRNAs/ miRNAs play an important regulatory role in the battle between virus and host, especially in regulating the transcription of virus and host genes, stability and translation of mRNAs, and host antiviral response [6]. Developing functional computational models and networks to predict potential SARS-CoV -miRNA/lncRNA association may benefit not only the understanding of COVID-19 mechanism at the noncoding RNA level, but also the detection of disease biomarkers for disease diagnosis, treatment, prognosis, and prevention. Surprisingly, known experimentally confirmed disease-lncRNA associations are still very limited. Since multiple ways of interaction between miRNAs, lncRNAs, and mRNA have been reported to play key roles in determining the cellular functions during viral infection, it is essential to discover these interactions in an integrated fashion to comprehensively decipher the networks and key regulatory noncoding-RNA hubs underpinning the pathology of SARS-CoV. Although we learned a great deal of coronavirus infection, the effective approaches for treatment are still scarce. Unsurprisingly, there is little knowledge of the detailed molecular interactions for the SARS-CoV infection crosstalk with noncoding RNAs network in the cell. Several signaling pathways regulate miRNAs and lncRNAs that affect the viral function and the infection progress, including replication, translation, and even modulating the host expression. Since it is also important to consider the virus-host protein-protein interaction in order to understand its pathogenesis during infection [7,8]; we used Viruses- STRING, a protein–protein interaction database specifically designed to analyze the virus-host interactions [9]. Subsequently, the Gene Set Enrichment Analysis (GSEA) was used to assess and interpret the coordinate pathways that might be potentially involved in these interactions [10]. Furthermore, we used the miRWalk2.0 database to generate a network for a comprehensive overview of miRNA-lncRNA interactions using experimentally verified data [11]. Our findings revealed a network of miRNAs/lncRNAs which regulate these pathways. Based on this, we designed a network-based model to propose the most important regulatory factors and hubs with a functional role in regulating the viral infection process using a noncoding RNA perspective.

Methods

Bioinformatic analyses

To generate an interactome network of Human SARS coronavirus (SARS-CoV) with human proteins, we used the STRING database http://viruses.string-db.org/ (version 10.5) [9]. Next, the Gene Set Enrichment Analysis (GSEA) (https://www.gsea-msigdb.org/) was performed for the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotations [10,12]. Then, the most important canonical pathways with the highest number of genes were selected. In order to disclose the most possible miRNAs regulating the selected mRNAs, the MiRTarBase (http://miRTarBase.cuhk.edu.cn/), one of the most important experimentally validated miRNA-target interactions (MTIs) databases, was employed. For the sake of accuracy, only functional MTIs were chosen for further studies [12]. Further, miRNA-lncRNA interactions were determined using the miRWalk2.0 database (http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/), a database on predicted and published noncoding RNAs; and seed length (SL) ≥ 13 were selected as the most significant interactions [11]. Finally, the lncRNA /miRNA/mRNA network was virtualized by Cytoscape 3.8.0. Hub targets were analyzed by cytoHubba package, a Cytoscape plug-in for finding hub objects in a network, and 5 top hub nodes with higher degrees were recognized.

Results

Protein-protein interaction (PPI) network of the SARS-CoV and human host cell

Human SARS coronavirus (SARS-CoV) and the Homo sapiens interaction network was downloaded as a vector image from the viruses STRING dataset. Protein-protein interactions were obtained and shaped a network with median confidence (scores greater than 0.4) between SARS-CoV and human host cells. The obtained protein-protein interactions are summarized in Fig. 1 . As depicted, 293 interactions were obtained and discovered a network, which included 40 proteins from the human host cell and 15 SARS-CoV-interacting proteins.
Fig. 1

Human SARS coronavirus (SARS-CoV) and Homo sapiens interaction network obtained from the viruses. STRING database. The human host cell (connector proteins in light green color) and SARS-CoV-interacting proteins (red proteins).

Human SARS coronavirus (SARS-CoV) and Homo sapiens interaction network obtained from the viruses. STRING database. The human host cell (connector proteins in light green color) and SARS-CoV-interacting proteins (red proteins).

Gene Ontology (GO) enrichment and canonical pathway analysis

As many as 100 terms were examined in the canonical pathway analysis. It was found that many of these pathways are central pathways, meaning that most of the genes involved in this network are associated with canonical pathways. 20 top canonical pathway terms such as TGF-beta signaling pathway (P value = 6.99E-21; gene count = 11), Wnt signaling pathway (P value = 4.09E-14; gene count = 9), MAPK signaling pathway (P value = 7.51E-12; gene count = 9) are shown in Fig. 2 and the genes involved in these pathways are shown in Table 1 . Among these 20 pathways, the TGF-beta signaling pathway with the highest number of genes was selected for further study. In addition, based on gene ontology, 100 terms were selected such as those associated with response to transforming growth factor-beta (P value = 3.22E-23; gene count = 15), transforming growth factor-beta receptor cytoplasmic mediator activity (P value = 2.95E-23; gene count = 8), cellular response to endogenous stimulus (P value = 8.03E-23; gene count = 23), transforming growth factor-beta receptor signaling pathway (P value = 7.79E-23; gene count = 14). The 20 top enriched GO functions are shown in Fig. 3 .
Fig. 2

Enriched KEGG pathways of the genes involved in SARS-CoV and Homo sapiens interaction network.

Table 1

The list of the genes involved in canonical pathways.

Canonical PathwaysGenes
KEGG_TGF_BETA_SIGNALING_PATHWAYSMAD3, SMAD4, SMAD2, MAPK1, TGFB1, TGFBR1, SMAD1, SMAD5, SMAD6, SMAD7, SMAD9
KEGG_WNT_SIGNALING_PATHWAYSMAD3, SMAD4, SMAD2, MAPK9, MAPK8, MAPK10, JUN, NFATC2, FOSL1
KEGG_MAPK_SIGNALING_PATHWAYMAPK9, MAPK8, MAPK10, JUN, NFATC2, MAPK1, TGFB1, TGFBR1, FOS
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAYMAPK1, MAPK9, MAPK8, MAPK10, JUN, FOS
KEGG_ERBB_SIGNALING_PATHWAYMAPK1, JUN, MAPK9, MAPK8, MAPK10, FOS, NFATC2, CD79A
KEGG_GNRH_SIGNALING_PATHWAYMAPK1, JUN, MAPK9, MAPK8, MAPK10, FOS, NFATC2, CD79A
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAYMAPK1, JUN, MAPK9, FOS, NFATC2, MAPK8, MAPK10, CD79A
KEGG_APOPTOSISBAX, BCL2L1, CYCS, APAF1
KEGG_CELL_CYCLETGFB1, SMAD3, SMAD4, SMAD2
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAYMAPK9, MAPK8, MAPK10
KEGG_JAK_STAT_SIGNALING_PATHWAYBCL2L1, JAK2, STAT3
KEGG_CHEMOKINE_SIGNALING_PATHWAYJAK2, STAT3, MAPK1
KEGG_P53_SIGNALING_PATHWAYBAX, CYCS, APAF1
Fig. 3

Enriched GO functions of the genes involved in SARS-CoV and Homo sapiens interaction network.

Enriched KEGG pathways of the genes involved in SARS-CoV and Homo sapiens interaction network. The list of the genes involved in canonical pathways. Enriched GO functions of the genes involved in SARS-CoV and Homo sapiens interaction network.

Construction of lncRNA-miRNA-mRNA network

In order to establish a lncRNA-miRNA-mRNA network, 11 genes, including SMAD3, SMAD4, SMAD2, MAPK1, TGFB1, TGFBR1, SMAD1, SMAD5, SMAD6, SMAD7, and SMAD9 involved in TGF-beta signaling pathway were selected. MiRNAs and lncRNAs were identified from the MiRTarBase and miRWalk algorithm, respectively. Our data revealed that 709 miRNAs target these mRNAs, among which 145 functional MTIs were found and were subsequently selected as the most important interactions for further examination. In addition, it was predicted that 256,846 specific lncRNAs interact with specific miRNAs and a total of 139 lncRNA-miRNA interactions with SL ≥ 13. To elucidate the functions of the lncRNAs acting as miRNA targets, a network of lncRNAs, miRNAs, and mRNAs was constructed and visualized with Cytoscape. As shown in Fig. 4 , the mRNA/lncRNA/miRNA network was composed of 248 nodes (130 lncRNA nodes, 109 miRNA nodes, 9 mRNA nodes), and 284 edges. The 5 top nodes in the network were recognized by CytoHubba, which include SMAD2, SMAD3, SMAD4, SMAD7, and TGFBR1. All interacting lncRNAs, miRNAs, and mRNAs are summarized in Table 2 .
Fig. 4

The lncRNA-miRNA-mRNA network. mRNAs (Green), miRNAs (blue) and lncRNA (orange).

Table 2

The predicted lncRNAs, miRNAs, and mRNAs associated with SARS-CoV infection.

mRNAmiRNAlncRNAs
SMAD2hsa-miR-155-5p
hsa-miR-200a-3p
hsa-miR-200b-3p
hsa-miR-484RP11-72I8.1
hsa-miR-148a-3pAC005154.6
hsa-let-7g-5p
hsa-miR-146a-5pLINC01010
hsa-miR-18a-5p
hsa-miR-18b-5p
hsa-miR-27a-3p
hsa-miR-27b-3p
hsa-miR-323a-3p
hsa-miR-128-3p
hsa-miR-425-5p
hsa-miR-486-5pRAB11B-AS1
hsa-miR-206LINC01531
CTC-458G6.
hsa-miR-503-3pRAP2C-AS1
hsa-miR-15b-5p
hsa-miR-205-5pLINC01451
hsa-miR-125a-5pSPACA6P-AS
FLJ42969
AC009878.2
hsa-miR-145-5pRP11-240G22.5
CTB-131B5.2
LINC00622
RP11-433J8.1
RP11-76I14.1
RP11-470E16.2
RP11-25I9.3
MUC19
hsa-miR-212-3pRP11-353N14.2
hsa-miR-132-3pRP11-537P22.2
SMAD3hsa-miR-200a-3p
hsa-miR-18a-5p
hsa-miR-193b-3p
hsa-miR-145-5pRP11-240G22.5
CTB-131B5.2
LINC00622
RP11-433J8.1
RP11-76I14.1
RP11-470E16.2
RP11-25I9.3
MUC19
hsa-miR-142-5p
hsa-miR-491-5pRP11-317J10.2
hsa-miR-92b-3p
hsa-miR-323a-3p
hsa-miR-708-5pLINC01193
RP11-69H14.6
RP11-875O11.2
hsa-miR-199a-5pAC144525.1
RP11-755B10.3
LINC00907
RP11-338N10.1
hsa-miR-145-3p
hsa-miR-590-5pSNHG1
hsa-miR-23a-3p
hsa-miR-23b-5pCTD-2560E9.5
RP11-455I9.1
RP11-102K13.5
hsa-miR-424-5pSNHG1
hsa-miR-29b-1-5pRP11-114G22.1
CTC-523E23.1
SMAD4hsa-miR-26a-5pRP11-38L15.2
hsa-miR-483-3pAC002059.10
RP11-7F17.8
RP11-366F6.2
hsa-miR-18a-5p
hsa-miR-17-5pchr22-38_28785274-29006793.1
RP11-17M16.2
hsa-miR-19a-3pLINC00261
RP11-707A18.1
hsa-miR-20a-5p
hsa-miR-203a-3p
hsa-miR-421LINC00862
hsa-miR-146a-5pLINC01010
hsa-miR-224-5pRP11-318A15.2
hsa-miR-125a-5pSPACA6P-AS
FLJ42969
AC009878.2
hsa-miR-125b-5pFLJ42969
AC009878.2
RP11-485O10.3
RP3-329A5.8
SPACA6P-AS
hsa-miR-199a-5pAC144525.1
RP11-755B10.3
LINC00907
RP11-338N10.1
hsa-miR-130a-3p
hsa-miR-301a-3pLINC00635
hsa-miR-454-3p
hsa-miR-182-5p
hsa-miR-130b-3pLINC00608
hsa-miR-19b-3p
hsa-miR-204-5pAC073130.1
RP11-430L3.1
hsa-miR-1260bLINC01359
RP11-575L7.4
AC007952.5
LINC00202-1
CTD-2515A14.1
CTD-2653D5.1
RP11-110H1.4
hsa-miR-205-5pLINC01451
hsa-miR-183-5pSMC2-AS1
AC004076.5
hsa-miR-34a-5pRP11-867G23.10
hsa-miR-27a-3p
hsa-miR-144-3p
hsa-miR-574-3pAC008060.7
chr22-38_28785274-29006793.1
CH17-351M24.1
RP4-742C19.13
hsa-miR-34a-3p
hsa-miR-31-5pRP11-177H2.1
RP11-863P13.1
RP11-426C22.5
hsa-miR-144-5pLINC01555
ELDR
SMAD7hsa-miR-217AC079779.6
hsa-miR-216a-5pRP11-1080G15.1
hsa-miR-25-3p
hsa-miR-21-5p
hsa-miR-20a-5p
hsa-miR-106b-5pEPN2-AS1
RP11-243E13.2
CTC-548K16.2
chr22-38_28785274-29006793.1
hsa-miR-93-5pRP11-486M23.3
hsa-miR-33a-3pXIST
FAM183CP
TRPC7-AS1
hsa-miR-520g-3pRP11-315E17.1
RP11-466A19.4
AC144831.1
hsa-miR-195-5pCTBP1-AS2
SLC7A11-AS1
hsa-miR-497-5pLINC01135
hsa-miR-424-5pSNHG1
hsa-miR-92b-3p
hsa-miR-185-5pHMMR-AS1
RP6-159A1.4
KCNQ1OT1
MIS18A-AS1
hsa-miR-4775RP4-671O14.5
LINC01149
LINC01206
CTD-2541J13.2
hsa-miR-519d-3pRP11-1099M24.6
hsa-miR-590-5pSNHG1
TGFBR1hsa-let-7c-5p
hsa-miR-128-3pGS1-600G8.5
hsa-miR-140-5p
hsa-miR-142-3p
hsa-miR-181a-5p
hsa-let-7g-5p
hsa-let-7b-5p
hsa-miR-202-5pCTD-2006H14.2
RP11-325K19.1
hsa-miR-27b-3p
hsa-miR-376c-3pBOLA3-AS1
ERICH3-AS1
hsa-miR-135b-5pRP11-528M18.2
ZRANB2-AS2
CTC-241N9.1
FAM25BP
RP11-96C23.14
CTD-2050N2.1
CTD-2165H16.4
RP4-555D20.2
hsa-miR-490-3pAC009264.1
RP3-512E2.2
hsa-miR-20a-5p
hsa-miR-181c-5pRP11-1049A21.2
hsa-miR-199a-5pAC144525.1
RP11-755B10.3
LINC00907
RP11-338N10.1
The lncRNA-miRNA-mRNA network. mRNAs (Green), miRNAs (blue) and lncRNA (orange). The predicted lncRNAs, miRNAs, and mRNAs associated with SARS-CoV infection.

Discussion

Over the last few decades, an overgrowing line of evidence indicated a link of noncoding RNA molecules with the gene regulatory networks including those controlling the disease pathogenesis [6]. Having the tight interaction between viral proteins with their host proteome, it is expected that the viral infection could influence the noncoding RNA network in humans. There is a current urgent need for studying the pathogenesis of human SARS-CoV which has hit the world in a tremendously ascending trend. Thus, a huge number of research groups are trying very hard to find rapid diagnostic methods, studying current treatment options, developing novel therapeutic options, and hopefully developing an effective vaccine. However, fine-tuning crosstalk between viral proteins and host noncoding RNA machinery is almost an under appreciated layer in this investigation race. On the other hand, studying the noncoding RNAs in response to SARS-CoV infection using wet-lab strategies or low-scale methods might not fit the current emergency call. Therefore, we aimed to follow a comprehensive bioinformatics approach to dissect the strongest possible changes in the noncoding RNA network in response to the viral infection in humans using the available online databases. Our in-silico analysis has built a network of protein-protein interaction between the Human SARS coronavirus (SARS-CoV) and host proteome (Fig. 1), as well as strong miRNA-mRNA-lncRNA crosstalk (Fig. 4 and Table 2) possibly modulating the human response to the viral infection. In this study, we have performed multiple layers of bioinformatics analyses in order to obtain a big picture of the most significant events that occurred following the virus-host interaction in terms of changes in cell signaling pathways and gene expression via noncoding RNAs. We applied the viruses. STRING online database as a powerful platform to explore the most significant protein-protein interactions between SARS-CoV viral particles and host proteome. Considering the median confidence scores greater than 0.4, our analysis predicted that 15 viral proteins might be interacting directly with 40 host proteins, as depicted in the network (Fig. 1). In order to gain a functional prediction of the interacting proteins, the list of obtained strong interactions was then reanalyzed using gene ontology and gene set enrichment analysis (GSEA). A more concentrated list of the major pathways involved were provided using these in silico techniques, among which the interacting genes showed a great association with the TGF-β signaling and its receptor cytoplasmic activity. Also, significant GO categories for overlapped genes using the threshold of P < 0.05 and FDR < 0.05 showed meaningful predicted changes in enriched GO functions of the genes involved in interaction network, including those controlling the transforming growth factor-beta, transforming growth factor-beta receptor cytoplasmic mediator activity, and cellular response to endogenous stimulus. Based on our data, it is assumed that SARS-CoV infection in mammals raises a high level of inflammatory and immune responses by direct viral-host protein interactions. There are also studies that have been shown the role of TGF-beta signaling pathway in SARS-CoV infection [[13], [14], [15]]. In an effort to decipher the probable non-coding RNAs molecules involved, we further analyzed the most significant abovementioned gene sets using the miRTarBase and miRWalk algorithm. This analysis resulted in a network of miRNA-mRNA and miRNA-lncRNA interaction illustrated in Fig. 4. Various mechanisms based on miRNA-mediated regulation of viruses have been reported [16]. This highly coordinated interaction may eventually result in positive outcomes with regard to the host immune response or in favor of viral proliferation [17,18]. This is highly depends on the miRNA target [19]. More precisely, the small noncoding RNA might act directly by guiding an Argonaute protein on the viral mRNA or might target a cellular transcript that is important in the host immune response against viral infection. Consistently, our analysis confirmed that a change in miRNA network targeting the main immune hub signaling pathways responding to SARS-CoV infection potentially act as important immune-modulatory mechanisms in mammals. These findings predict a highly immunogenic viral-host interaction which may be very promising with regard to vaccine development. Collectively, in this in silico-based study, we reported possible way by which SARS-CoV infection can alter the miRNA network activity, and discussed a scenario in which the host miRNA can function either by modulating the host immune response transcripts or by directly targeting viral transcripts. Thus, it is quite possible that our knowledge of targeting the viral transcript by miRNA machinery can be exploited to develop novel antiviral therapeutic strategies.

Declaration of Competing Interest

The authors declare that there is no conflict of interest.
  18 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

2.  miRWalk2.0: a comprehensive atlas of microRNA-target interactions.

Authors:  Harsh Dweep; Norbert Gretz
Journal:  Nat Methods       Date:  2015-08       Impact factor: 28.547

3.  Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.

Authors:  Catherine L Jopling; Minkyung Yi; Alissa M Lancaster; Stanley M Lemon; Peter Sarnow
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

4.  The COVID-19 Pandemic in the US: A Clinical Update.

Authors:  Saad B Omer; Preeti Malani; Carlos Del Rio
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 6.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways.

Authors:  Thomas Treiber; Nora Treiber; Gunter Meister
Journal:  Nat Rev Mol Cell Biol       Date:  2019-01       Impact factor: 94.444

7.  SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway.

Authors:  Shih-Wein Li; Ching-Ying Wang; Yu-Jen Jou; Tsuey-Ching Yang; Su-Hua Huang; Lei Wan; Ying-Ju Lin; Cheng-Wen Lin
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

8.  Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.

Authors:  Sepideh Sadegh; Julian Matschinske; David B Blumenthal; Gihanna Galindez; Tim Kacprowski; Markus List; Reza Nasirigerdeh; Mhaned Oubounyt; Andreas Pichlmair; Tim Daniel Rose; Marisol Salgado-Albarrán; Julian Späth; Alexey Stukalov; Nina K Wenke; Kevin Yuan; Josch K Pauling; Jan Baumbach
Journal:  Nat Commun       Date:  2020-07-14       Impact factor: 14.919

9.  A potential treatment of COVID-19 with TGF-β blockade.

Authors:  WanJun Chen
Journal:  Int J Biol Sci       Date:  2020-04-21       Impact factor: 6.580

Review 10.  Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals.

Authors:  Nkerorema Djodji Damas; Nicolas Fossat; Troels K H Scheel
Journal:  Noncoding RNA       Date:  2019-01-14
View more
  11 in total

1.  Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype.

Authors:  Dinesh Devadoss; Arpan Acharya; Marko Manevski; Dominika Houserova; Michael D Cioffi; Kabita Pandey; Madhavan Nair; Prem Chapagain; Mehdi Mirsaeidi; Glen M Borchert; Siddappa N Byrareddy; Hitendra S Chand
Journal:  iScience       Date:  2022-06-30

2.  Risk stratification by long non-coding RNAs profiling in COVID-19 patients.

Authors:  Jie Cheng; Xiang Zhou; Weijun Feng; Min Jia; Xinlu Zhang; Taixue An; Minyuan Luan; Yi Pan; Shu Zhang; Zhaoming Zhou; Lei Wen; Yun Sun; Cheng Zhou
Journal:  J Cell Mol Med       Date:  2021-03-23       Impact factor: 5.310

3.  A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.

Authors:  Pedro Martínez-Fleta; Paula Vera-Tomé; María Jiménez-Fernández; Silvia Requena; Emilia Roy-Vallejo; Ancor Sanz-García; Marta Lozano-Prieto; Celia López-Sanz; Alicia Vara; Ángel Lancho-Sánchez; Enrique Martín-Gayo; Cecilia Muñoz-Calleja; Arantzazu Alfranca; Isidoro González-Álvaro; José María Galván-Román; Javier Aspa; Hortensia de la Fuente; Francisco Sánchez-Madrid
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

4.  Long non-coding RNA AC087388.1 as a novel biomarker in colorectal cancer.

Authors:  Arash Poursheikhani; Mohammad Reza Abbaszadegan; Mohammad Amin Kerachian
Journal:  BMC Cancer       Date:  2022-02-21       Impact factor: 4.430

Review 5.  SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.

Authors:  Lucia Natarelli; Fabio Virgili; Christian Weber
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 6.  Non-Coding RNAs in COVID-19: Emerging Insights and Current Questions.

Authors:  Tobias Plowman; Dimitris Lagos
Journal:  Noncoding RNA       Date:  2021-08-31

7.  Plasma miRNA profile at COVID-19 onset predicts severity status and mortality.

Authors:  Asier Fernández-Pato; Ana Virseda-Berdices; Salvador Resino; Pablo Ryan; Oscar Martínez-González; Felipe Pérez-García; María Martin-Vicente; Daniel Valle-Millares; Oscar Brochado-Kith; Rafael Blancas; Amalia Martínez; Francisco C Ceballos; Sofía Bartolome-Sánchez; Erick Joan Vidal-Alcántara; David Alonso; Natalia Blanca-López; Ignacio Ramirez Martinez-Acitores; Laura Martin-Pedraza; María Ángeles Jiménez-Sousa; Amanda Fernández-Rodríguez
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 8.  Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19.

Authors:  Dana R Julian; Megan A Kazakoff; Akhil Patel; Jesse Jaynes; Monte S Willis; Cecelia C Yates
Journal:  Curr Pathobiol Rep       Date:  2021-12-08

9.  Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.

Authors:  Fee Faysal Ahmed; Md Selim Reza; Md Shahin Sarker; Md Samiul Islam; Md Parvez Mosharaf; Sohel Hasan; Md Nurul Haque Mollah
Journal:  PLoS One       Date:  2022-04-07       Impact factor: 3.240

Review 10.  Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease.

Authors:  Alexandra Ioana Moatar; Aimee Rodica Chis; Catalin Marian; Ioan-Ovidiu Sirbu
Journal:  Int J Mol Sci       Date:  2022-08-17       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.